title: Effect of rosiglitazone, a PPAR-γ ligand on haloperidol-induced catalepsy.
authors.forename: Gaurav
authors.initials: G
authors.lastname: Gupta
authors.forename: Ramandeep
authors.initials: R
authors.lastname: Singh
authors.forename: Sheba Rani
authors.initials: SR
authors.lastname: David
authors.forename: Rohit Kumar
authors.initials: RK
authors.lastname: Verma
mesh_terms: D000818:Animals; D002375:Catalepsy / Q000139:chemically induced*; D006220:Haloperidol / Q000494:pharmacology*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008024:Ligands; D008297:Male; D051379:Mice; D018384:Oxidative Stress / Q000187:drug effects; D047495:PPAR gamma / Q000819:agonists*; D000077154:Rosiglitazone; D012601:Scopolamine / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000378:metabolism; D045162:Thiazolidinediones / Q000494:pharmacology*
chemical_list: D007004:Hypoglycemic Agents; D008024:Ligands; D047495:PPAR gamma; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D012601:Scopolamine; D013482:Superoxide Dismutase; D006220:Haloperidol